H
Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
KRX:293480
Price:
11 010
KRW
0.82%
Market Closed
Market Cap:
190.5B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Hana Pharm Co Ltd
11010
+90 (+0.82%)
| 52 Week Range |
10 150
14 380
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Hana Pharm Co Ltd
Income Statement
Earnings Waterfall
Hana Pharm Co Ltd
Hana Pharm Co Ltd
|
Revenue
|
225.2B
KRW
|
|
Cost of Revenue
|
-86.7B
KRW
|
|
Gross Profit
|
138.5B
KRW
|
|
Operating Expenses
|
-116.5B
KRW
|
|
Operating Income
|
22.1B
KRW
|
|
Other Expenses
|
-2.5B
KRW
|
|
Net Income
|
19.5B
KRW
|
Income Statement
Hana Pharm Co Ltd
Hana Pharm Co Ltd
Currency: KRW
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Revenue |
147 137
N/A
|
145 999
-1%
|
152 833
+5%
|
156 766
+3%
|
159 379
+2%
|
163 384
+3%
|
166 347
+2%
|
168 322
+1%
|
169 060
+0%
|
172 619
+2%
|
177 306
+3%
|
180 041
+2%
|
186 792
+4%
|
191 424
+2%
|
196 407
+3%
|
202 631
+3%
|
205 176
+1%
|
209 975
+2%
|
210 845
+0%
|
214 229
+2%
|
220 494
+3%
|
221 575
+0%
|
224 457
+1%
|
227 413
+1%
|
223 549
-2%
|
225 193
+1%
|
|
| Gross Profit | |||||||||||||||||||||||||||
| Cost of Revenue |
(47 322)
|
(45 940)
|
(50 926)
|
(52 344)
|
(53 375)
|
(54 809)
|
(56 150)
|
(57 860)
|
(58 901)
|
(61 279)
|
(63 283)
|
(63 159)
|
(64 987)
|
(65 182)
|
(65 589)
|
(69 735)
|
(72 511)
|
(77 502)
|
(79 605)
|
(81 031)
|
(82 841)
|
(82 823)
|
(84 872)
|
(85 796)
|
(83 801)
|
(86 662)
|
|
| Gross Profit |
99 815
N/A
|
100 059
+0%
|
101 907
+2%
|
104 422
+2%
|
106 005
+2%
|
108 576
+2%
|
110 197
+1%
|
110 462
+0%
|
110 157
0%
|
111 338
+1%
|
114 023
+2%
|
116 881
+3%
|
121 805
+4%
|
126 243
+4%
|
130 818
+4%
|
132 896
+2%
|
132 666
0%
|
132 473
0%
|
131 240
-1%
|
133 198
+1%
|
137 653
+3%
|
138 752
+1%
|
139 584
+1%
|
141 617
+1%
|
139 747
-1%
|
138 531
-1%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(66 538)
|
(67 256)
|
(68 344)
|
(70 509)
|
(72 978)
|
(75 356)
|
(76 631)
|
(78 017)
|
(78 596)
|
(79 336)
|
(82 348)
|
(85 957)
|
(87 182)
|
(92 810)
|
(94 808)
|
(94 520)
|
(97 570)
|
(97 914)
|
(100 069)
|
(103 120)
|
(106 264)
|
(109 507)
|
(112 553)
|
(113 796)
|
(115 997)
|
(116 458)
|
|
| Selling, General & Administrative |
(64 768)
|
(66 190)
|
(65 463)
|
(69 515)
|
(70 180)
|
(71 645)
|
(72 553)
|
(73 182)
|
(73 622)
|
(74 150)
|
(76 908)
|
(80 724)
|
(81 288)
|
(86 711)
|
(88 293)
|
(87 848)
|
(90 362)
|
(90 146)
|
(91 824)
|
(93 656)
|
(96 497)
|
(99 041)
|
(101 505)
|
(103 205)
|
(104 946)
|
(104 318)
|
|
| Research & Development |
0
|
0
|
(2 191)
|
(1 036)
|
(1 862)
|
(2 431)
|
(2 562)
|
(2 795)
|
(2 982)
|
(3 142)
|
(3 242)
|
(3 303)
|
(3 303)
|
(3 320)
|
(3 489)
|
(3 663)
|
(3 983)
|
(4 413)
|
(4 748)
|
(5 860)
|
(6 171)
|
(6 853)
|
(7 404)
|
(6 966)
|
(7 392)
|
(8 508)
|
|
| Depreciation & Amortization |
0
|
0
|
(690)
|
(478)
|
(787)
|
(1 131)
|
(1 515)
|
(1 761)
|
(1 992)
|
(2 146)
|
(2 197)
|
(2 481)
|
(2 592)
|
(2 862)
|
(3 026)
|
(3 009)
|
(3 224)
|
(3 355)
|
(3 497)
|
(3 560)
|
(3 575)
|
(3 613)
|
(3 644)
|
(3 666)
|
(3 700)
|
(3 632)
|
|
| Other Operating Expenses |
(1 770)
|
(1 066)
|
0
|
520
|
(149)
|
(149)
|
0
|
(279)
|
0
|
102
|
0
|
551
|
0
|
83
|
0
|
0
|
0
|
0
|
0
|
(44)
|
(21)
|
0
|
0
|
41
|
41
|
0
|
|
| Operating Income |
33 276
N/A
|
32 802
-1%
|
33 563
+2%
|
33 913
+1%
|
33 027
-3%
|
33 220
+1%
|
33 566
+1%
|
32 446
-3%
|
31 562
-3%
|
32 003
+1%
|
31 675
-1%
|
30 923
-2%
|
34 622
+12%
|
33 433
-3%
|
36 010
+8%
|
38 377
+7%
|
35 096
-9%
|
34 559
-2%
|
31 171
-10%
|
30 078
-4%
|
31 389
+4%
|
29 245
-7%
|
27 031
-8%
|
27 822
+3%
|
23 750
-15%
|
22 073
-7%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
(899)
|
(659)
|
100
|
1 017
|
1 791
|
2 303
|
2 101
|
1 685
|
1 476
|
1 265
|
1 131
|
1 012
|
998
|
822
|
695
|
682
|
507
|
(174)
|
(188)
|
(473)
|
(51)
|
339
|
834
|
1 210
|
1 536
|
1 806
|
|
| Non-Reccuring Items |
0
|
0
|
(147)
|
0
|
0
|
0
|
(279)
|
0
|
101
|
0
|
170
|
0
|
83
|
0
|
0
|
0
|
64
|
65
|
(44)
|
0
|
0
|
(32)
|
41
|
0
|
0
|
44
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
41
|
0
|
16
|
38
|
37
|
53
|
62
|
166
|
544
|
544
|
839
|
982
|
27
|
20
|
(275)
|
(653)
|
(104)
|
(115)
|
(121)
|
(5)
|
(16)
|
20
|
37
|
35
|
|
| Total Other Income |
(1 333)
|
(1 328)
|
(1 225)
|
(1 158)
|
(323)
|
(337)
|
(563)
|
(531)
|
(786)
|
(1 064)
|
(5 025)
|
(5 353)
|
(5 339)
|
(5 939)
|
(885)
|
(996)
|
(876)
|
259
|
(116)
|
2
|
98
|
(415)
|
17
|
(135)
|
265
|
495
|
|
| Pre-Tax Income |
31 044
N/A
|
30 813
-1%
|
32 332
+5%
|
33 773
+4%
|
34 511
+2%
|
35 226
+2%
|
34 862
-1%
|
33 653
-3%
|
32 415
-4%
|
32 368
0%
|
28 495
-12%
|
27 125
-5%
|
31 203
+15%
|
29 299
-6%
|
35 847
+22%
|
38 082
+6%
|
34 515
-9%
|
34 055
-1%
|
30 718
-10%
|
29 492
-4%
|
31 316
+6%
|
29 132
-7%
|
27 907
-4%
|
28 917
+4%
|
25 589
-12%
|
24 454
-4%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
(6 271)
|
(6 510)
|
(6 163)
|
(6 412)
|
(5 935)
|
(5 878)
|
(6 558)
|
(6 528)
|
(7 197)
|
(6 419)
|
(13 603)
|
(13 335)
|
(13 898)
|
(12 562)
|
(7 833)
|
(8 433)
|
(7 713)
|
(9 529)
|
(6 411)
|
(5 970)
|
(5 947)
|
(5 405)
|
(5 574)
|
(5 820)
|
(5 171)
|
(4 908)
|
|
| Income from Continuing Operations |
24 773
|
24 303
|
26 169
|
27 361
|
28 575
|
29 346
|
28 304
|
27 123
|
25 218
|
25 950
|
14 893
|
13 791
|
17 305
|
16 737
|
28 014
|
29 650
|
26 802
|
24 526
|
24 307
|
23 522
|
25 369
|
23 726
|
22 333
|
23 097
|
20 417
|
19 545
|
|
| Income to Minority Interest |
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
24 775
N/A
|
24 304
-2%
|
26 170
+8%
|
27 362
+5%
|
28 576
+4%
|
29 346
+3%
|
28 304
-4%
|
27 123
-4%
|
25 218
-7%
|
25 950
+3%
|
14 893
-43%
|
13 791
-7%
|
17 305
+25%
|
16 737
-3%
|
28 014
+67%
|
29 650
+6%
|
26 802
-10%
|
24 526
-8%
|
24 307
-1%
|
23 522
-3%
|
25 369
+8%
|
23 726
-6%
|
22 333
-6%
|
23 097
+3%
|
20 417
-12%
|
19 545
-4%
|
|
| EPS (Diluted) |
1 769.64
N/A
|
1 736
-2%
|
1 744.66
+0%
|
1 520.11
-13%
|
1 587.55
+4%
|
1 726.23
+9%
|
1 572.44
-9%
|
1 595.47
+1%
|
1 483.41
-7%
|
1 526.47
+3%
|
860.74
-44%
|
797.06
-7%
|
1 056.12
+33%
|
967.48
-8%
|
1 679.05
+74%
|
1 713.9
+2%
|
1 549.28
-10%
|
1 417.7
-8%
|
1 405.08
-1%
|
1 359.68
-3%
|
1 466.45
+8%
|
1 371.49
-6%
|
1 290.95
-6%
|
1 335.11
+3%
|
1 180.22
-12%
|
1 129.82
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
